Volume 15, Number 8—August 2009
Research
Serologic Evidence of Frequent Human Infection with WU and KI Polyomaviruses
Table
Age distribution of patients (419 samples) who were seropositive for WUPyV, KIPyV, or both, St. Louis, Missouri, USA, November 2007–October 2008*
| Age group | No. (%) seropositive |
||
|---|---|---|---|
| KIPyV VP1 | WUPyV VP1 | Both | |
| <6 mo | 13 (43.3) | 25 (83.3) | 13 (43.3) |
| 6 mo–<1 y | 7 (24.1) | 13 (44.8) | 7 (24.1) |
| 1 y | 12 (40) | 18 (60) | 10 (33.3) |
| 2 y | 13 (43.3) | 18 (60) | 10 (33.3) |
| 3 y | 15 (50) | 17 (56.7) | 10 (33.3) |
| 4 y | 22 (73.3) | 20 (66.7) | 16 (53.3) |
| 5 y | 28 (93.3) | 26 (86.7) | 24 (80) |
| 6–8 y | 26 (86.7) | 27 (90) | 24 (80) |
| 9–12 y | 30 (100) | 27(90) | 27 (90) |
| 13–19 y | 28 (93.3) | 28 (93.3) | 27 (90) |
| 20–34 y | 21 (70) | 30 (100) | 21(70) |
| 35–49 y | 22 (73.3) | 29 (96.7) | 22 (73.3) |
| 50–64 y | 19 (63.3) | 24 (80) | 19 (63.3) |
| 65–79 y |
22 (73.3) |
28 (93.3) |
22 (73.3) |
| Total | 278 (66.3) | 330 (78.7) | 252 (60.1) |
*WUPyV, WU polyomavirus; KIPyV, KI polyomavirus; WUPyV VP1, WUPyV viral protein 1; KIPyV VP1, KIPyV viral protein 1.


